{"id":"https://openalex.org/W4323966262","doi":"https://doi.org/10.1055/s-0037-1613856","title":"A Comparative, Double-blind, Randomised Trial of a New Second Generation LMWH (Bemiparin) and UFH in the Prevention of Post-operative Venous Thromboembolism","display_name":"A Comparative, Double-blind, Randomised Trial of a New Second Generation LMWH (Bemiparin) and UFH in the Prevention of Post-operative Venous Thromboembolism","alternate_titles":[],"publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W4323966262","doi":"https://doi.org/10.1055/s-0037-1613856","mag":"2169761080","pmid":"https://pubmed.ncbi.nlm.nih.gov/10780310"},"language":"en","primary_location":{"id":"doi:10.1055/s-0037-1613856","doi":"https://doi.org/10.1055/s-0037-1613856","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0037-1613856","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4323966262"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058616887","display_name":"J. Howes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139260","display_name":"Thrombosis Research Institute","ror":"https://ror.org/050r8mq79","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210139260"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Howes","raw_affiliation_strings":["From the Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK","institution_ids":["https://openalex.org/I4210139260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055158655","display_name":"V. Sharma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139260","display_name":"Thrombosis Research Institute","ror":"https://ror.org/050r8mq79","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210139260"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"V. Sharma","raw_affiliation_strings":["From the Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK","institution_ids":["https://openalex.org/I4210139260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064219103","display_name":"Z. Kadziola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139260","display_name":"Thrombosis Research Institute","ror":"https://ror.org/050r8mq79","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210139260"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Z. Kadziola","raw_affiliation_strings":["From the Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK","institution_ids":["https://openalex.org/I4210139260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108347528","display_name":"V V Kakkar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139260","display_name":"Thrombosis Research Institute","ror":"https://ror.org/050r8mq79","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210139260"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"V. V. Kakkar","raw_affiliation_strings":["From the Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK","institution_ids":["https://openalex.org/I4210139260"]}]},{"author_position":"last","author":{"id":null,"display_name":"the Bemiparin Assessment group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"the Bemiparin Assessment group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.1045,"has_fulltext":false,"cited_by_count":82,"citation_normalized_percentile":{"value":0.96474635,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"83","issue":"04","first_page":"523","last_page":"529"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/low-molecular-weight-heparin","display_name":"low molecular weight heparin","score":0.9350000023841858},{"id":"https://openalex.org/keywords/unfractionated-heparin","display_name":"unfractionated heparin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/thromboprophylaxis","display_name":"thromboprophylaxis","score":0.902999997138977},{"id":"https://openalex.org/keywords/postoperative-thrombosis","display_name":"postoperative thrombosis","score":0.8349999785423279},{"id":"https://openalex.org/keywords/hip-arthroplasty","display_name":"total hip arthroplasty","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bleeding-complications","display_name":"bleeding complications","score":0.8140000104904175},{"id":"https://openalex.org/keywords/anti-xa-activity","display_name":"anti-Xa activity","score":0.7860000133514404},{"id":"https://openalex.org/keywords/antithrombin-iii","display_name":"antithrombin III","score":0.777999997138977},{"id":"https://openalex.org/keywords/tissue-factor-pathway-inhibitor","display_name":"tissue factor pathway inhibitor","score":0.9490000009536743},{"id":"https://openalex.org/keywords/coagulation-parameters","display_name":"coagulation parameters","score":0.7860000133514404},{"id":"https://openalex.org/keywords/wound-hematoma","display_name":"wound hematoma","score":0.7990000247955322},{"id":"https://openalex.org/keywords/elective-surgery","display_name":"elective surgery","score":0.38600000739097595}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9736981391906738},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8099286556243896},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5837264657020569},{"id":"https://openalex.org/C2776884760","wikidata":"https://www.wikidata.org/wiki/Q2750727","display_name":"Low molecular weight heparin","level":3,"score":0.580974817276001},{"id":"https://openalex.org/C2991741193","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thromboembolism","level":3,"score":0.5585315823554993},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.5311450362205505},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5223411321640015},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.51938396692276},{"id":"https://openalex.org/C2780011451","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thrombosis","level":3,"score":0.5158085823059082},{"id":"https://openalex.org/C3017811039","wikidata":"https://www.wikidata.org/wiki/Q166019","display_name":"Major bleeding","level":3,"score":0.46582314372062683},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4491007626056671},{"id":"https://openalex.org/C2778336525","wikidata":"https://www.wikidata.org/wiki/Q708178","display_name":"Arthroplasty","level":2,"score":0.4430779218673706},{"id":"https://openalex.org/C2776265017","wikidata":"https://www.wikidata.org/wiki/Q220570","display_name":"Pulmonary embolism","level":2,"score":0.4316059350967407},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4301873445510864},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.37731683254241943},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2132609784603119},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.07580870389938354},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006495","descriptor_name":"Heparin, Low-Molecular-Weight","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006495","descriptor_name":"Heparin, Low-Molecular-Weight","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006495","descriptor_name":"Heparin, Low-Molecular-Weight","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011183","descriptor_name":"Postoperative Complications","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011655","descriptor_name":"Pulmonary Embolism","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013923","descriptor_name":"Thromboembolism","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019106","descriptor_name":"Postoperative Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D019644","descriptor_name":"Arthroplasty, Replacement, Hip","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020246","descriptor_name":"Venous Thrombosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1055/s-0037-1613856","doi":"https://doi.org/10.1055/s-0037-1613856","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0037-1613856","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},{"id":"pmid:10780310","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10780310","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and haemostasis","raw_type":"Clinical Trial"},{"id":"mag:2169761080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10780310","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W19505608","https://openalex.org/W70359381","https://openalex.org/W176762677","https://openalex.org/W1554127422","https://openalex.org/W1600823549","https://openalex.org/W1969379131","https://openalex.org/W2001204795","https://openalex.org/W2004964926","https://openalex.org/W2009455361","https://openalex.org/W2015732515","https://openalex.org/W2032253855","https://openalex.org/W2034991772","https://openalex.org/W2051723405","https://openalex.org/W2066160685","https://openalex.org/W2068789219","https://openalex.org/W2079144418","https://openalex.org/W2082790428","https://openalex.org/W2085904727","https://openalex.org/W2086088447","https://openalex.org/W2115688804","https://openalex.org/W2116807909","https://openalex.org/W2138478053","https://openalex.org/W2333206452","https://openalex.org/W4324113883"],"related_works":["https://openalex.org/W2037446571","https://openalex.org/W2107235506","https://openalex.org/W2394508488","https://openalex.org/W2009216358","https://openalex.org/W1376558","https://openalex.org/W2135525689","https://openalex.org/W2013921930","https://openalex.org/W2060136446","https://openalex.org/W2054930725"],"abstract_inverted_index":{"A":[0,204],"randomised,":[1],"prospective,":[2],"double-blind":[3],"trial":[4],"was":[5,131],"performed,":[6],"to":[7,35,86,89],"compare":[8],"the":[9,26,47,91,105,116,123,128,150,169,179,188,210,240,284],"safety":[10],"and":[11,20,52,68,99,119,140,187,223,236],"efficacy":[12],"of":[13,28,49,61,74,93,101,135,152,159,190,206,225,258,280,286],"a":[14,64,77,228,253,278],"new":[15],"low-molecular-weight":[16],"heparin":[17,23],"(LMWH)":[18],"Bemiparin":[19],"standard":[21],"unfractionated":[22],"(UFH),":[24],"for":[25],"prophylaxis":[27],"postoperative":[29,181,287],"venous":[30,96],"thromboembolism.":[31],"300":[32],"patients":[33,56,70,109,191,265],"scheduled":[34],"undergo":[36],"elective":[37],"hip":[38,267],"arthroplasty":[39,268],"were":[40,46,82,145],"included.":[41],"The":[42,79],"principal":[43],"outcome":[44],"measures":[45],"incidence":[48],"thromboembolic":[50],"events":[51],"bleeding":[53,102,153,156],"complications.":[54],"149":[55,69],"received":[57,71],"3,500":[58,259],"anti-Xa":[59,260],"IU":[60,73,261,282],"bemiparin":[62,117,241],"plus":[63],"placebo":[65],"injection":[66],"daily":[67,255,276],"5,000":[72,281],"UFH":[75,124,273],"twice":[76,275],"day.":[78],"two":[80,129],"groups":[81,130],"similar":[83],"with":[84,213,245],"respect":[85],"factors":[87],"likely":[88],"affect":[90],"risk":[92,100,264],"developing":[94],"post-operative":[95,106,214],"thromboembolism":[97],"(VTE)":[98],"events.":[103],"During":[104],"period,":[107],"34":[108],"developed":[110,193],"VTE":[111,126],"complications;":[112],"9":[113],"(7.2%)":[114],"in":[115,122,127,149,239,252,262,283],"group":[118,242],"25":[120],"(18.7%)":[121],"group.":[125],"statistically":[132],"significant":[133,147],"(OR":[134,161,196],"2.96;":[136],"95%":[137,163,198],"CI":[138,164,199],"1.32-6.62":[139],"p":[141,166,201],"=":[142,167,176,185,202],"0.01).":[143],"There":[144],"no":[146],"differences":[148],"frequency":[151],"complications:":[154],"major":[155],"requiring":[157],"discontinuation":[158],"prophylaxis,":[160],"1.21;":[162],"0.36-4.05;":[165],"1.00),":[168],"measured":[170],"median":[171,180],"operative":[172],"blood":[173],"loss":[174,183],"(p":[175,184],"0.77)":[177],"or":[178],"drain":[182],"0.97),":[186],"number":[189],"who":[192],"wound":[194],"haematoma":[195],"0.87;":[197],"0.31-2.46;":[200],"1.00).":[203],"comparison":[205],"coagulation":[207],"parameters":[208],"on":[209],"preoperative":[211],"day":[212,215,219,224],"2":[216],"+/-":[217,221],"1,":[218],"6":[220],"1":[222],"discharge":[226],"showed":[227],"significantly":[229],"higher":[230],"AT":[231],"concentration,":[232],"anti-factor":[233],"Xa":[234],"activity":[235],"TFPI":[237],"levels":[238],"when":[243],"compared":[244],"UFH.":[246],"This":[247],"study":[248],"demonstrates":[249],"that":[250],"bemiparin,":[251],"single":[254],"subcutaneous":[256],"dose":[257,279],"high":[263],"undergoing":[266],"is":[269],"more":[270],"effective":[271],"than":[272],"administered":[274],"at":[277],"prevention":[285],"VTE.":[288],"Both":[289],"agents":[290],"are":[291],"equally":[292],"safe.":[293]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4323966262","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-03-13T00:00:00"}
